Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-06-27, Stock:ABBV, The news for the past five days is as follows:
2019-06-20: NEWS1: 3 Drugs Under FDA Review With Blockbuster Potential.NEWS2: 3 Drugs Under FDA Review With Blockbuster Potential.NEWS3: AbbVie Declares Quarterly Dividend.NEWS4: Is AbbVie (ABBV) a Great Value Stock Right Now?.NEWS5: Is AbbVie (ABBV) a Great Value Stock Right Now?.NEWS6: These New Product Launches Could Partially Offset Humira’s Losses.
2019-06-21: NEWS1: Novo Nordisk's Haemophilia A Drug Esperoct Gets EU Approval.NEWS2: Novo Nordisk's Haemophilia A Drug Esperoct Gets EU Approval.NEWS3: Novo Nordisk's Haemophilia A Drug Esperoct Gets EU Approval.NEWS4: Notable Friday Option Activity: ABBV, VLO, KNX.NEWS5: Notable Friday Option Activity: ABBV, VLO, KNX.NEWS6: Top Ranked Income Stocks to Buy for June 21st.NEWS7: Daily Dividend Report: WASH, MDT, CL, ABBV, UDR.NEWS8: Daily Dividend Report: WASH, MDT, CL, ABBV, UDR.NEWS9: Sanofi/Regeneron's Asthma Candidate Meets Goal in Study.NEWS10: Sanofi/Regeneron's Asthma Candidate Meets Goal in Study.NEWS11: Top Ranked Income Stocks to Buy for June 21st.NEWS12: Sanofi/Regeneron's Asthma Candidate Meets Goal in Study.
2019-06-24: NEWS1: AbbVie (ABBV) Dips More Than Broader Markets: What You Should Know.NEWS2: Forget Bargain Hunting: Tap 5 Stocks With Rising P/E.NEWS3: FDA lifts  hold on one of AbbVie's trials of venetoclax.NEWS4: AbbVie Announces US FDA Lifts Partial Clinical Hold on Phase 3 Study of Venetoclax in Patients with Multiple Myeloma Positive for the t(11;14) Genetic Abnormality.NEWS5: Forget Bargain Hunting: Tap 5 Stocks With Rising P/E.
2019-06-25: NEWS1: What Happened in the Stock Market Today.NEWS2: What Happened in the Stock Market Today.NEWS3: AbbVie + Allergan: Where Are The Synergies?.NEWS4: AbbVie + Allergan: Where Are The Synergies?.NEWS5: SHAREHOLDER ALERT: WeissLaw LLP Investigates Allergan Plc.NEWS6: US Stock Market Overview &#8211; Stocks Drop on US/Iran Conflict.NEWS7: Surging Allergan Stock Is Approaching AbbVie’s Bid Price.NEWS8: The Dow Fell Because the Trump-Xi Meeting May Cover More Than Just Trade.NEWS9: What Happened in the Stock Market Today.NEWS10: Dow Ends Lower, Stocks Fall as Powell Says Fed 'Grappling' with Rate Cut.NEWS11: AbbVie + Allergan: Where Are The Synergies?.NEWS12: Pharma Buying Spree Continues As AbbVie Takes Out Allergan For $63 Billion.NEWS13: Abbvie Drops by a Record as Allergan Deal Fails to End Doubts.NEWS14: AbbVie (ABBV) Stock Falls After $63 Billion Allergan Acquisition Announcement.NEWS15: Allergan Options Bull Wins Big on AbbVie Buyout Buzz.NEWS16: Stocks Fall as Powell Says Fed 'Grappling' with Interest Rate Cut.NEWS17: Health Care Sector Update for 06/25/2019: BPMX,AGN,ABBV,CNAT,NVS.NEWS18: Is The AbbVie-Allergan Deal as Bad for AbbVie as the Market Seems to Think?.NEWS19: Stock Market News: AbbVie Bets Big; Can Microsoft Stay on Top?.NEWS20: AbbVie Shareholders Will Get No Vote on Purchase of Allergan.NEWS21: Allergan Finance, LLC -- Moody's reviews Allergan's Baa3 ratings for upgrade.NEWS22: Stocks Lower as Powell Says Fed 'Grappling' on Whether to Trim Interest Rates.NEWS23: Abbvie Decides to Acquire Allergan.NEWS24: DGRO, VZ, ABBV, MRK: Large Inflows Detected at ETF.NEWS25: AbbVie is Now Oversold (ABBV).NEWS26: Why AbbVie Stock Is Sinking and Allergan Is Soaring Today.NEWS27: Wall Street Voices Skepticism on AbbVie's Aggressive Allergan Acquisition.NEWS28: AbbVie Buys Allergan for Over $60 Billion.NEWS29: Stock Market News: AbbVie Bets Big; Can Microsoft Stay on Top?.NEWS30: AbbVie Gets a Shot in the Arm With Allergan Buy, but Now Look Elsewhere.NEWS31: Will David Tepper Be Happy about the AbbVie-Allergan Deal?.NEWS32: AbbVie Announces Lifting of FDA's Partial Hold on CANOVA Study.NEWS33: S&P 500 Movers: ABBV, AGN.NEWS34: AbbVie to Buy Botox-Maker Allergan, Look Ahead to G-20.NEWS35: AbbVie’s $63 Billion Mega Deal Returns Focus to Debt-Fueled M&A.NEWS36: AbbVie's $18 Billion Blowup Brings Deal Deja Vu to Some Holders.NEWS37: AbbVie Is Buying Allergan. Wall Street Has Doubts..NEWS38: AbbVie Buys Allergan for $63 Billion: Was the Price Just Right?.NEWS39: Allergan Agrees to $63 Billion Takeover From AbbVie in Blockbuster Pharma Deal.NEWS40: Why AbbVie Stock Is Sinking and Allergan Is Soaring Today.NEWS41: What to Watch in The Markets: AbbVie-Allergan, Micron, Buffett, and More.NEWS42: AbbVie looks beyond Humira with $63 bln deal for Botox-maker Allergan.NEWS43: Zacks.com featured highlights include: Crocs, Brinker, Shoe Carnival, AbbVie and Criteo.NEWS44: I Believe AbbVie and Allergan Need Each Other.NEWS45: I Believe AbbVie and Allergen Need Each Other.NEWS46: Shares of Botox Maker Allergan Get a Lift.NEWS47: AbbVie Stock’s Already Big Dividend Yield Is Getting a Boost From Its Deal for Allergan.NEWS48: SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Regarding Whether the Sale of Allergan plc to AbbVie Inc. is Fair to Shareholders.NEWS49: AbbVie’s $63 Billion Mistake.NEWS50: Think AbbVie Is Overpaying for Allergan? Pfizer Offered Way More in 2015.NEWS51: The 10 Biggest Biotech Stocks.NEWS52: US STOCKS-Wall St dragged down by Iran tensions, trade worries; Fed in focus.NEWS53: Stocks Slide Ahead of Fed Chairman's Remarks, G-20 Concerns.NEWS54: Abbvie Decides to Acquire Allergan.NEWS55: Stock market skids lower in early action ahead of Powell speech.NEWS56: AbbVie’s Bid for Allergan Has Specialty Drugmaker Stocks Rallying.NEWS57: AbbVie’s $63 Billion Allergan Deal Gives Life to Industry.NEWS58: AbbVie to Buy Botox-Maker Allergan, Look Ahead to G-20.NEWS59: Stocks Turn Red; Dow Jones Stock McDonald's, Lennar Eye Buy Points.NEWS60: AbbVie Is Buying Allergan and Wall Street Is Doubtful.NEWS61: Health Care Sector Update for 06/25/2019: AGN, GMDA, DERM, JNJ, PFE, ABT, MRK, AMGN.NEWS62: Stocks Open Flat; Dow Jones Stock McDonald's, Lennar Eye Buy Points.NEWS63: Baupost's Klarman Loses in Allergan Deal While Tepper Gets a Win.NEWS64: Stocks see flat start as investors await remarks by Fed chairman.NEWS65: AbbVie buying Irish drug firm Allergan in $63 billion deal.NEWS66: AbbVie Is Buying Botox-Maker Allergan In A $63 Billion Takeover.NEWS67: AbbVie’s $63 Billion Mistake.NEWS68: Another Day, Another Deal: What to Watch from AbbVie, Allergan, Micron, Buffett.NEWS69: Allergan Is a $63 Billion Botox Job for AbbVie.NEWS70: Zacks.com featured highlights include: Crocs, Brinker, Shoe Carnival, AbbVie and Criteo.NEWS71: AbbVie Receives Positive Recommendation from the Institut national d'excellence en santé et en services sociaux (INESSS) for the Combination VENCLEXTA® With Rituximab as a Treatment for Patients With Chronic Lymphocytic Leukemia.NEWS72: AbbVie Joins Giant Acquisition Trend in Big Pharma With Allergan Deal.NEWS73: Pre-Market Most Active for Jun 25, 2019 :  ABBV, AGN, NOK, TEVA, GFI, QQQ, ARQL, AMD, GOLD, SQQQ, TVIX, TQQQ.NEWS74: Stock Futures Mixed; Dow Jones Stock McDonald's, Lennar Eye Buy Points.NEWS75: Stocks to watch: Allergan, Altran, Tesco, William Hill, Asos, Iliad.NEWS76: AbbVie Is Likely to Decline as Investors Digest Its Takeover Announcement.NEWS77: AbbVie to acquire Botox maker Allergan for $63bn.NEWS78: AbbVie looks beyond Humira with $63 billion deal for Botox-maker Allergan.NEWS79: AbbVie Fizzles, Gold, Bitcoin and (Some) Biotech Sizzles.NEWS80: AbbVie to Buy Allergan in a $63 Billion Deal.NEWS81: AbbVie Inc. -- Moody's affirms AbbVie's Baa2 ratings; outlook stable.NEWS82: AbbVie confirms deal to buy Allergan for 45% premium, valuing Allergan at $61.7 billion.NEWS83: UPDATE 2-AbbVie to buy Botox-maker Allergan in $63 bln deal.NEWS84: AbbVie to buy Botox-maker Allergan in $63 billion deal.NEWS85: AbbVie to Acquire Allergan in Transformative Move for Both Companies.NEWS86: Allergan's stock soars after WSJ report AbbVie near a buyout deal for a 45% premium.NEWS87: Allergan&apos;s stock soars after WSJ report AbbVie near a buyout deal for a 45% premium.
2019-06-26: NEWS1: Is Allergan a Good Deal for AbbVie?.NEWS2: AbbVie Rebounds as Market Warms to Allergan Deal, Botox Potential.NEWS3: AbbVie Is 'The New Cash King' As It Takes On Botox-Maker Allergan.NEWS4: Morphic Holding IPO: What You Need To Know.NEWS5: Wednesday’s Vital Data: AbbVie, FedEx and Micron.NEWS6: Wednesday’s Vital Data: AbbVie, FedEx and Micron.NEWS7: AbbVie to Buy Allergan: Prescribed ETFs.NEWS8: AbbVie to Buy Allergan: Prescribed ETFs.NEWS9: Elliott Management Advocated for an Allergan Split Prior to Sale.NEWS10: Company News For Jun 26, 2019.NEWS11: Company News For Jun 26, 2019.NEWS12: 3 Big Stock Charts for Wednesday: Tyson Foods, Lennar and State Street.NEWS13: 3 Big Stock Charts for Wednesday: Tyson Foods, Lennar and State Street.NEWS14: The Zacks Analyst Blog Highlights: AbbVie, Allergan, Bristol-Myers and Celgene.NEWS15: The Zacks Analyst Blog Highlights: AbbVie, Allergan, Bristol-Myers and Celgene.NEWS16: AbbVie to Acquire Allergan in Nearly $62B Cash & Stock Deal.NEWS17: AbbVie to Acquire Allergan in Nearly $62B Cash & Stock Deal.NEWS18: Here's Why Nobody's Happy About This $63 Billion Buyout.NEWS19: Here's Why Nobody's Happy About This $63 Billion Buyout.NEWS20: Big Pharma Has to Bet Big on M&A. Investors Don’t..NEWS21: AbbVie to Buy Allergan: Prescribed ETFs.NEWS22: AbbVie's $63 billion Allergan deal shakes up big pharma.NEWS23: Company News For Jun 26, 2019.NEWS24: Health Care Sector Update for 06/26/2019: ACST, ABBV, EYEG, NBRV, AGN, JNJ, PFE, ABT, MRK, AMGN.NEWS25: Health Care Sector Update for 06/26/2019: ACST, ABBV, EYEG, NBRV, AGN, JNJ, PFE, ABT, MRK, AMGN.NEWS26: AbbVie to Acquire Allergan in Nearly $62B Cash & Stock Deal.NEWS27: The Zacks Analyst Blog Highlights: AbbVie, Allergan, Bristol-Myers and Celgene.NEWS28: Here&apos;s Why Nobody&apos;s Happy About This $63 Billion Buyout.NEWS29: AbbVie Stock Is Rising as Some See ‘Considerable’ Opportunity in Selloff.NEWS30: AbbVie's Allergan Deal Sets Up Another Trade In Big Biotech.NEWS31: Pre-Market Most Active for Jun 26, 2019 :  HIVE, VICI, PBR, MU, AMD, BB, QQQ, ABBV, NOK, TVIX, TQQQ, SQQQ.NEWS32: Pre-Market Most Active for Jun 26, 2019 :  HIVE, VICI, PBR, MU, AMD, BB, QQQ, ABBV, NOK, TVIX, TQQQ, SQQQ.NEWS33: AbbVie Announces Acquisition of Allergan: What You Should Know.NEWS34: Allergan acquisition is ‘a major bailout’ for shareholders, according to analysts.NEWS35: AbbVie Rises 3%.NEWS36: AbbVie Inc. - Rule 2.10 Announcement - Relevant Securities in Issue.NEWS37: Podcast: AbbVie Falls 16% After Merger Announcement.NEWS38: Validea John Neff Strategy Daily Upgrade Report - 6/26/2019.NEWS39: Validea John Neff Strategy Daily Upgrade Report - 6/26/2019.NEWS40: Replay: What to Watch in The Markets: AbbVie-Allergan, Micron, Buffett, and More.NEWS41: 5 Top Stock Trades for Wednesday — AGN, ABBV, FDX, MSFT, BB.NEWS42: Nasdaq Today: Hard to Keep Track of the Losers.NEWS43: Nasdaq Today: Hard to Keep Track of the Losers.

Answer: Rise